Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2014; 20(13): 3615-3619
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3615
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3615
Table 2 Demographics, clinical features and response patterns of the subjects to the Helicobacter pylori eradication regimes n (%)
| Factor | Seven-day arm | Ten-day arm | P value |
| Age range (mean ± SD) | 13-71 (41.56 ± 16.94) | 18-80 (44.93 ± 16.94) | 0.504 |
| Sex | 0.581 | ||
| Male | 6 (33.3) | 12 (41.4) | |
| Female | 12 (66.7) | 17 (58.6) | |
| Symptomatic improvement | 0.215 | ||
| Yes | 17 (94.4) | 29 (100.0) | |
| No | 1 (5.6) | 0 (0.0) | |
| Successful eradication | 0.789 | ||
| Yes | 16 (88.9) | 25 (86.2) | |
| No | 2 (11.1) | 4 (13.8) | |
-
Citation: Onyekwere CA, Odiagah JN, Igetei R, Duro Emanuel AO, Ekere F, Smith S. Rabeprazole, clarithromycin, and amoxicillin
Helicobacter pylori eradication therapy: Report of an efficacy study. World J Gastroenterol 2014; 20(13): 3615-3619 - URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3615.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3615